Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
In a landmark phase 2 trial published this week, researchers demonstrated that rogaratinib—a fibroblast growth factor receptor (FGFR) inhibitor—showed significant efficacy against succinate dehydrogenase-deficient gastrointestinal stromal tumors (GISTs), a rare ... Read More
Continuous Coverage
The two young men who walked into the Islamic Center of San Diego on a Saturday afternoon in…
San Antonio police arrested a suspect in 2026 for using Instagram’s direct messaging system to groom and lure…
Dr. Mary Wettach, a general dentist from Mount Pleasant, has been appointed as Southeast District Dental Society Trustee…
The Lyric Opera of Chicago has secured a transformative $20 million endowment gift from the Illinois-based Negaunee Foundation.…
RE—INC, the lifestyle brand co-founded by Megan Rapinoe and Christen Press, has expanded its “Football Loves You” apparel…
Exotic animal diagnostics merge AI precision with clinical urgency, yet tech gaps persist in real-time decision-making tools. Veterinary…
Global Affairs
On May 26, 2026, the Gospel reading from Mark 10:28-31—“Many who are first will be last, and the…
Markets And Money
Crude oil prices are in a tight range as geopolitical risks in the Strait of Hormuz clash with…
Digital Culture
After 20 years, Nvidia’s control panel is being retired, signaling a shift in GPU software ecosystems. The transition…
Science And Wellbeing
The Cruise Ship Outbreak: A Hantavirus Crisis and the Science Behind the Response A hantavirus outbreak linked to…
Screen And Sound
Dame Julie Andrews, the legendary actress best known for *Mary Poppins* and *The Sound of Music*, made a…
Fixtures And Form
Joao Fonseca’s French Open second-round clash against Dino Prizmic on Day 4 of Roland-Garros 2026 becomes a tactical…
